Pharmascience Inc. — licence 100241, currently licensed, last inspection rating C (2025-03-20).
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02481464 | APO-DEXTROAMPHETAMINE SR | APOTEX INC | Capsule (Sustained-Release) | DEXTROAMPHETAMINE SULFATE 10 MG | Approved |
| 02481472 | APO-DEXTROAMPHETAMINE SR | APOTEX INC | Capsule (Sustained-Release) | DEXTROAMPHETAMINE SULFATE 15 MG | Approved |
| 01924516 | DEXEDRINE | KNIGHT THERAPEUTICS INC. | Tablet | DEXTROAMPHETAMINE SULFATE 5 MG | Marketed |
| 01924567 | DEXEDRINE SPANSULE | KNIGHT THERAPEUTICS INC. | Capsule (Sustained-Release) | DEXTROAMPHETAMINE SULFATE 15 MG | Marketed |
| 01924559 | DEXEDRINE SPANSULE | KNIGHT THERAPEUTICS INC. | Capsule (Sustained-Release) | DEXTROAMPHETAMINE SULFATE 10 MG | Marketed |
| 02443236 | DEXTROAMPHETAMINE | AA PHARMA INC | Tablet | DEXTROAMPHETAMINE SULFATE 5 MG | Marketed |
| 02448319 | TEVA-DEXTROAMPHETAMINE SR | TEVA CANADA LIMITED | Capsule (Sustained-Release) | DEXTROAMPHETAMINE SULFATE 10 MG | Marketed |
| 02448327 | TEVA-DEXTROAMPHETAMINE SR | TEVA CANADA LIMITED | Capsule (Sustained-Release) | DEXTROAMPHETAMINE SULFATE 15 MG | Marketed |
| 02447673 | PMS-DEXTROAMPHETAMINE | PHARMASCIENCE INC | Tablet | DEXTROAMPHETAMINE SULFATE 5 MG | Cancelled Pre Market |
8 active FDA Drug Master Files.